While both are called medullary carcinoma, these cancers differ in many ways: ...
Miacalcin is a form of calcitonin which is a hormone that we produce in the body. Calcitonin slows down our bone losses so that our own bone building can get caught up and even increase bone density.
It is specifically designed to bind to and activate amylin and calcitonin receptors, both of which play roles in regulating aspects of metabolism, such as appetite. The once-weekly injectable drug ...
Calcitonin-salmon (rDNA origin) 200 IU/spray; nasal spray. Correct hypocalcemia and other disorders (eg, Vit. D deficiency) prior to initiating; monitor serum calcium during therapy. Supplement ...
Interventions: Oral alendronate 5mg, oral alfacalcidol 1 µg or intranasal calcitonin 200IU daily. Methods: We used the effects on bone mineral density (BMD) in head-to-head trials together with ...
AbbVie and Gubra Announce License Agreement to Develop an Amylin Analog for the Treatment of Obesity
NORTH CHICAGO, IL, USA and HØRSHOLM, Denmark I March 3, 2025 I AbbVie (NYSE: ABBV) and Gubra A/S (CPSE:GUBRA), a company specializing in preclinical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback